GSK3B and colitis: To examine the in vivo effects of CO or GSK-3β inhibitor (LiCl) on survival of DSS-induced colitis mice, we inhaled mice with CO (250 ppm) for 4 h or administrated LiCl (200 mg/kg, i.p.)on daily basis to mice for more 6 days.